3095-81-6

Basic information

• Product Name: Pyridine,4,4'-(1,4-phenylenedi-2,1-ethenediyl)bis-
• Synonyms: Pyridine,4,4'-(p-phenylenedivinylene)di- (6CI,7CI,8CI);1,4-Bis[2-(4-pyridyl)ethenyl]benzene; p-Bis(2-(pyridin-4-yl)ethenyl)benzene
• CAS NO: 3095-81-6
• Molecular Formula: C20H16 N2
• Molecular Weight: 284.36
• Mol File: 3095-81-6.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 481.5°Cat760mmHg
• Flash Point: 183.6°C
• Density: 1.173g/cm³
• CAS DataBase Reference: Pyridine,4,4'-(1,4-phenylenedi-2,1-ethenediyl)bis-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine,4,4'-(1,4-phenylenedi-2,1-ethenediyl)bis-(3095-81-6)
• EPA Substance Registry System: Pyridine,4,4'-(1,4-phenylenedi-2,1-ethenediyl)bis-(3095-81-6)

Safety Data

• Hazardous Substances Data: 3095-81-6(Hazardous Substances Data)

Upstream product

• 108-89-4 picoline 
• 623-27-8 terephthalaldehyde, 
• 100-43-6 4-vinylpyridine 
• 106-37-6 1.4-dibromobenzene 
• 872-85-5 pyridine-4-carbaldehyde 
• 4546-04-7 tetraethyl 1,4-xylylenediphosphonate 
• 47868-63-3 1,4-xylylene-bis(triphenylphosphonium chloride) 
• 106-42-3 para-xylene 
• 623-24-5 1,4-bis(bromomethyl)benzene 
• 1449-46-3 benzyltriphenylphosphonium bromide 
• 118528-62-4 4-<2-(4-pyridyl)ethenyl>benzaldehyde 
• 623-25-6 p-Xylylene dichloride 
• 40817-03-6 p-xylenebis(triphenylphosphonium) dibromide 
• 105-06-6 1,4-Divinylbenzene 

Downstream Products

• 517863-58-0 [AgBF₄*((E,E)-N,N'-bis(pyridylethylene)benzene] 
• 1021495-30-6 6,9-(1,4-bis[β-(4-pyridyl)vinyl]benzene)2-arachno-B10H12 
• 1021495-32-8 N,N'-bis[9-Me2S-arachno-B10H12-6-yl](1,4-bis[β-(4-pyridyl)vinyl]benzene) 
• 1021495-39-5 4-(1,4-bis[β-(4-pyridyl)vinyl]benzene)-arachno-B9H13 
• 1021495-38-4 N,N'-bis[arachno-B9H13-4-yl](1,4-bis[β-(4-pyridyl)vinyl]benzene) 
• 1021465-62-2 (bis-1,4-(4-pyridylethyl-enyl)benzene)(Pt(PEt₃)2)2 

Relevant articles and documents

Multicolor luminescent supramolecular hydrogels based on cucurbit[8]uril and OPV derivative

Supramolecular hydrogels have received considerable attention because of their various fascinating applications. Herein, an alkyl chain-modified oligo(p-phenylenevinylene) (Py-OPV) derivative was synthesized. When assembled with cucurbit[7]uril, its fluor

New viologen analogs: 1,4-bis[2-(pyridin-4-yl)ethenyl]benzene quaternary salts

Alkylation of 1,4-bis[2-(pyridin-4-yl)ethenyl]benzene with alkyl p-toluenesulfonates and dimethyl sulfate gave new viologen analogs, 1-alkyl-4-(2-{4-[2-(1-alkylpyridinium-4-yl)ethenyl]phenyl}ethenyl)-pyridinium bis(p-toluenesulfonates) and sulfate. Their

Synthesis of some new distyrylbenzene derivatives using immobilized Pd on an NHC-functionalized MIL-101(Cr) catalyst: photophysical property evaluation, DFT and TD-DFT calculations

In this study the catalytic application of a heterogeneous Pd-catalyst system based on metal organic framework [Pd-NHC-MIL-101(Cr)] was investigated in the synthesis of distyrylbenzene derivatives using the Heck reaction. The Pd-NHC-MIL-101(Cr) catalyst s

A pyridine chain conjugated system polymer derivatives and its preparation method and application (by machine translation)

The invention discloses a pyridine chain conjugated system polymer derivatives and its preparation method and application, relates to the field of organic synthetic technology. The compounds of the invention have the general formula 1, formula 2, formula 3 or formula 4 four kinds of structure; wherein R1 To bromine, methyl, tert-butyl, methoxy, ester or amide group; m is 2 or 3; formula 2 R in the2 Bromo, ester group, amido group or a carboxyl group; R3 Is hydrogen, fluoro, methyl, methoxy, ester or amide; formula 3 or formula 4 in the X is a carbon atom or a nitrogen atom; R4 Hydrogen, methyl, fluorine, chlorine, bromine or nitro; Y is a carbon atom or a nitrogen atom; Z is imino or oxygen atom. The invention synthetic compounds of rotenone induced PC12 cell injury has obvious protection functions, and to α - Syn protein aggregation and fibrosis has obvious inhibition, statistical significance, may be further developed to be used for the treatment of Parkinson's drug; the general formula 1 - general formula 4 are respectively: (by machine translation)